Susquehanna Fundamental Investments, LLC Agios Pharmaceuticals, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

  • $4.33 Trillion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$33.21 - $46.54 $753,867 - $1.06 Million
-22,700 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$33.87 - $55.93 $237,089 - $391,510
7,000 Added 44.59%
22,700 $795,000
Q2 2020

Aug 14, 2020
BUY
$34.45 - $53.48 $540,865 - $839,636
15,700 New
15,700 $840,000

Others Institutions Holding AGIO

# of Institutions
232
Shares Held
58.1M
Call Options Held
403K
Put Options Held
469K
View Full List

About AGIOS PHARMACEUTICALS, INC.

AGIO Quotes by TradingView
  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $3.05B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Susquehanna Fundamental Investments, LLC Portfolio

Follow Susquehanna Fundamental Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email